(Q51115170)

30 March 2018

title

Ethological analysis of cholecystokinin (CCKA and CCKB) receptor ligands in the elevated plus-maze test of anxiety in mice. (English)

1 reference

30 March 2018

1 reference

1 reference

N J Johnson

1

1 reference

30 March 2018

R J Rodgers

series ordinal

2

1 reference

30 March 2018

publication date

1 April 1996

1 reference

30 March 2018

number of pages

10

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

30 March 2018

volume

124

1 reference

30 March 2018

page(s)

355-364

1 reference

30 March 2018

issue

4

1 reference

30 March 2018

https://scigraph.springernature.com/pub.10.1007/bf02247441

exact match

0 references

cites work

Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings

1 reference

https://api.crossref.org/works/10.1007%2FBF02247441

The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02247441

Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02247441

Brief presentation of the story and present status of studies of the vertebrate cholinergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02247441

The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02247441

Evidence that CCKB receptors mediate the regulation of exploratory behaviour in the rat

21 January 2018

1 reference

12 December 2020

Pentagastrin infusions in patients with panic disorder. I. Symptoms and cardiovascular responses.

1 reference

12 December 2020

Anxiolytic effects of CCK-B antagonists

1 reference

12 December 2020

Cholecystokinin and Pancreozymin, one single Hormone?

1 reference

12 December 2020

Antianxiety and behavioral suppressant actions of the novel 5-HT1A receptor agonist, flesinoxan

1 reference

12 December 2020

Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol.

1 reference

12 December 2020

Evidence for potentiation by CCK antagonists of the effect of cholecystokinin octapeptide in the elevated plus-maze.

1 reference

12 December 2020

Anxiolytic-like effect of (S)-WAY 100135, a 5-HT1A receptor antagonist, in the murine elevated plus-maze test.

1 reference

12 December 2020

Characterization of Receptors for Cholecystokinin and Related Peptides in Mouse Cerebral Cortex

1 reference

12 December 2020

Ethological comparison of the effects of diazepam and acute/chronic imipramine on the behaviour of mice in the elevated plus-maze.

1 reference

12 December 2020

Involvement of D2 dopaminergic receptors in the emotional and motivational responses induced by injection of CCK-8 in the posterior part of the rat nucleus accumbens.

1 reference

12 December 2020

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

1 reference

12 December 2020

CCK in animal and human research on anxiety

1 reference

12 December 2020

Two brain cholecystokinin receptors: implications for behavioral actions.

1 reference

12 December 2020

Ethopharmacological analysis of the effects of putative 'anxiogenic' agents in the mouse elevated plus-maze.

1 reference

12 December 2020

Anxiogenic-like action of caerulein, a CCK-8 receptor agonist, in the mouse: influence of acute and subchronic diazepam treatment

1 reference

12 December 2020

Failure of intravenous pentagastrin challenge to induce panic-like effects in rhesus monkeys.

1 reference

12 December 2020

The use of a plus-maze to measure anxiety in the mouse

1 reference

12 December 2020

Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder

1 reference

12 December 2020

Effects of BOC-CCK-4 and L 365.260 on cortical 5-HT release in guinea-pigs on exposure to the elevated plus maze

1 reference

12 December 2020

Cholecystokinin and anxiety: promises and pitfalls.

1 reference

12 December 2020

Dopamine D1 and D2 receptor ligands modulate the behaviour of mice in the elevated plus-maze.

1 reference

12 December 2020

Effects of cholecystokinin tetrapeptide and sulfated cholecystokinin octapeptide in rat models of anxiety.

1 reference

12 December 2020

The influence of 5-hydroxytryptamine re-uptake blockade on CCK receptor antagonist effects in the rat elevated zero-maze.

1 reference

12 December 2020

Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience

1 reference

12 December 2020

Cholecystokinin receptor binding in brain and pancreas: regulation of pancreatic binding by cyclic and acyclic guanine nucleotides

1 reference

12 December 2020

Anxiogenic stimuli in the elevated plus-maze.

1 reference

12 December 2020

Cholecystokinin-induced anxiety: how is it reflected in studies on exploratory behaviour?

1 reference

12 December 2020

Brain cholecystokinin tetrapeptide levels are increased in a rat model of anxiety.

1 reference

12 December 2020

Anxiogenic-like effects of fluprazine and eltoprazine in the mouse elevated plus-maze: profile comparisons with 8-OH-DPAT, CGS 12066B, TFMPP and mCPP.

1 reference

12 December 2020

Interaction of cholecystokinin with specific membrane receptors on pancreatic acinar cells

1 reference

12 December 2020

Heterogeneity of CCK-B receptors involved in animal models of anxiety

1 reference

12 December 2020

The benzodiazepine antagonist flumazenil blocks the effects of CCK receptor agonists and antagonists in the elevated plus-maze.

1 reference

12 December 2020

Social isolation of rats increases the density of cholecystokinin receptors in the frontal cortex and abolishes the anti-exploratory effect of caerulein.

1 reference

12 December 2020

Evidence for an involvement of the brain cholecystokinin B receptor in anxiety

1 reference

12 December 2020

Lack of effect of CCKB receptor antagonists in ethological and conditioned animal screens for anxiolytic drugs.

1 reference

12 December 2020

Lasting effects on rodent anxiety of a single exposure to a cat.

1 reference

12 December 2020

Ondansetron, an antagonist of 5-HT3 receptors, antagonizes the anti-exploratory effect of caerulein, an agonist of CCK receptors, in the elevated plus-maze.

1 reference

12 December 2020

Determination of cholecystokinin tetrapeptide and cholecystokinin octapeptide sulfate in different rat brain regions by high-pressure liquid chromatography with electrochemical detection

1 reference

12 December 2020

Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety.

1 reference

12 December 2020

Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity

1 reference

12 December 2020

Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice.

1 reference

12 December 2020

Opposite effects mediated by CCKA and CCKB receptors in behavioural and hormonal studies in rats

1 reference

12 December 2020

Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety.

1 reference

12 December 2020

Study of induced effects by selective CCKB agonists cholecystokinin in the nociception and behavior in rodents

1 reference

12 December 2020

An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro 16-6028) in the murine elevated plus-maze

1 reference

12 December 2020

Biological actions of cholecystokinin

1 reference

12 December 2020

'Anxiolytic' effect of CCK-antagonists on plus-maze behavior in mice.

1 reference

12 December 2020

Anxiolytic-like effects of yohimbine in the murine plus-maze: strain independence and evidence against alpha 2-adrenoceptor mediation.

1 reference

12 December 2020

New peptide in the vertebrate CNS reacting with antigastrin antibodies

1 reference

12 December 2020

The cholecystokinin hypothesis of panic and anxiety disorders: a review

1 reference

12 December 2020

Cholecystokinin and anxiety

1 reference

12 December 2020

Anxiety enhancement in the murine elevated plus maze by immediate prior exposure to social stressors.

1 reference

12 December 2020

Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02247441

1 reference

30 March 2018

PubMed ID

8739551

1 reference

30 March 2018